Determination of adequacy of analgesia in vaginal delivery with persistent intravenous analgesia with remifentanil compared to epidural analgesia

Determination of adequacy of analgesia and satisfaction of vaginal delivery women with persistent intravenous analgesia with remifentanil infusion and comparing it with epidural analgesia

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190325043107N14

Enrollment

Registered

2019-12-15

Start date

2020-01-05

Completion date

Unknown

Last updated

2019-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain. Pain disorders related to psychological factors

Interventions

Intervention 1: Intervention group: Intervention group women (Remifentanil group) will dissolve 4 mg Remifentanil in 100cc normal saline solution (40µg/ml) and the drug will be infused through infusio

Eligibility

Sex/Gender

Female

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Perform vaginal delivery

Exclusion criteria

Exclusion criteria: Women candidates for cesarean section

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: Every hour for two days. Method of measurement: Visual Analogue Scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSoodabeh Karimi

Tabriz University of Medical Sciences

s.karimi.h@gmail.com+98 41 3334 7054

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026